3 unknown, 2 completed, 2 terminated, 1 withdrawn. 8 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Unknown 3, Completed 2, Terminated 2, Withdrawn 1 |
| Phase 2 | 4 | Unknown 3, Terminated 1 |
Follow Convalescent plasma: new trials by email Literature Review of Convalescent plasma trials Research Report on Convalescent plasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19 Convalescent plasma - COVID-19 Pneumonia, Convalescent Plasma | Phase 1 / Phase 2 | Unknown | Universidad Autonoma de Coahuila | 15 | 2020-07-06 | 2020-07-07 |
| Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection Convalescent Plasma, Standard of Care - COVID19 | Phase 1 / Phase 2 | Unknown | Cairo University | 67 | 2020-06-01 | 2020-09-29 |
| CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 convalescent plasma - COVID-19, SARS-CoV 2 | Phase 1 / Phase 2 | Unknown | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 90 | 2020-05-20 | 2020-06-05 |
| Safety in Convalescent Plasma Transfusion to COVID-19 Convalescent Plasma - COVID-19 | Phase 1 | Terminated | TecSalud Investigación Clínica | 12 | 2020-05-08 | 2021-02-10 |
| Convalescent Plasma Therapy in Patients With COVID-19 Convalescent plasma - Convalescence, Corona Virus Infection | Phase 1 | Completed | Biofarma | 10 | 2020-05-01 | 2020-06-30 |
| Convalescent Plasma Therapy - Zurich Protocol Convalescent plasma - COVID-19 | Phase 1 | Completed | University of Zurich | 30 | 2020-04-29 | 2021-05-03 |
| Convalescent Plasma vs. Standard Plasma for COVID-19 Convalescent Plasma, Standard Donor Plasma - COVID | Phase 1 / Phase 2 | Terminated | Stony Brook University | 82 | 2020-04-08 | 2021-12-06 |
| Intermediate IND Severe Illness COVID-19 CP SARS-CoV-2 plasma - Severe Acute Respiratory Syndrome, COVID | Phase 1 | Withdrawn | Henry Ford Health System | 2020-04-07 | 2025-12-19 |
COVID-19 (6) · Convalescence (2) · Coronavirus Infections (1) · Plaque, Amyloid (1) · Severe Acute Respiratory Syndrome (1)
Biofarma (1) · Cairo University (1) · Henry Ford Health System (1) · Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (1) · Stony Brook University (1) · TecSalud Investigación Clínica (1) · Universidad Autonoma de Coahuila (1) · University of Zurich (1)
Mexico (3) · United States (2) · Egypt (1) · Indonesia (1) · Switzerland (1)
Debra J Levan, DO (1) · Elliott Bennett-Guerrero, MD (1) · Luis M Villela, MD (1) · Markus Manz, Professor (1) · Nana Sarnadi, Sp.OG (1) · Shukri David, MD (1)
PMID 11023960, PMID 20370679, PMID 25457751, PMID 32125452, PMID 32219428, PMID 33870923, PMID 34013969, PMID 34104878, PMID 35482408, PMID 36734509, PMID 37162745, PMID 3898484